Open access
2,148
Views
2
CrossRef citations to date
0
Altmetric
Articles
Effectiveness of cyclosporine A in patients with moderate to severe plaque psoriasis in a real-life clinical setting in Italy: the TRANSITION study
F. Marsilia Unit of Dermatology, Versilia Hospital, Lido di Camaiore, Lucca, ItalyView further author information
, M. Travaglinib Centro per la cura della Psoriasi, Hospital “Di Summa-Perrino”, Brindisi, ItalyView further author information
, G. Stincoc Institute of Dermatology, Department of Medicine, University Hospital, Udine, ItalyView further author information
, R. Manzonid Division of Dermatology, Azienda Sanitaria Locale of Biella, Ponderano, ItalyView further author information
, R. Tiberioe SCDU Dermatology, AOU Maggiore della Carità, Novara, ItalyView further author information
, F. Prignanof Department of Health Science Dermatology Unit, University of Florence, Firenze, ItalyView further author information
, A. Mazzottag Dermatology Unit, San Camillo-Forlanini Hospital, Rome, ItalyView further author information
, S. P. Cannavòh Dermatology Unit, University Hospital Policlinico “G. Martino”, Messina, ItalyView further author information
, A. Cucciai Unit of Dermatology, San Donato Hospital, Arezzo, ItalyView further author information
, M. Germinoj Department of Dermatology, Hospital Policlinico Città di Udine, Udine, ItalyView further author information
, M. R. Bongiornok Dermatology Unit, University Hospital Policlinico “P. Giaccone”, Palermo, ItalyView further author information
, S. Persechinol Dermatology Unit, NESMOS Department, S. Andrea Hospital, University of Rome “Sapienza”, Rome, ItalyView further author information
, T. Floriom Dermatology Unit, Hospital Di Venere-Carbonara di Bari, Bari, ItalyView further author information
, M. Pettinaton Dermatology Unit, University Hospital “Policlinico-Vittorio Emanuele”, Catania, ItalyView further author information
, M. Tabanellio U.O.C. Dermatologia Ravenna AUSL Romagna, Ospedale Santa Maria delle Croci, Ravenna, ItalyView further author information
, R. Sarkarp Novartis Pharma AG, Basel, SwitzerlandView further author information
, E. Aloisiq Novartis Farma SpA, Origgio, ItalyCorrespondence[email protected]
View further author information
, View further author information
M. Bartezaghiq Novartis Farma SpA, Origgio, ItalyView further author information
& R. Orsenigoq Novartis Farma SpA, Origgio, ItalyView further author information
show all
Pages 401-407
|
Received 27 Feb 2020, Accepted 03 Mar 2020, Published online: 30 Apr 2020
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.